AGREEMENT
QuickLinks -- Click here to rapidly navigate through this document
EXHIBIT 99.1
This will confirm the agreement by and among the undersigned that the Amendment No. 2 to Schedule 13D filed with respect to the beneficial ownership by the undersigned of shares of common stock, par value $.001 per share of SeraCare, Inc. (now known as Biomat USA, Inc.), is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(2) under the Securities Exchange Act of 1934.
IN WITNESS WHEREOF, the undersigned have executed this agreement as of the 25th day of May, 2004.
| PROBITAS PHARMA, S.A. | ||||
By: |
/s/ XXXXXX GRIFOLS XXXXX Xxxxxx Grifols Xxxxx Chief Executive Officer |
|||
INSTITUTO GRIFOLS, S.A. |
||||
| By: | /s/ XX. XXXXXX XXXXX Xx. Xxxxxx Xxxxx Chief Executive Officer |
|||
AGREEMENT
